Flecainide induced ventricular fibrillation in a neonate.
作者信息
Ackland F, Singh R, Thayyil S
出版信息
Heart. 2003 Oct;89(10):1261. doi: 10.1136/heart.89.10.1261.
Abstract
摘要
相似文献
1
Flecainide induced ventricular fibrillation in a neonate.氟卡尼在一名新生儿中诱发了心室颤动。
Heart. 2003 Oct;89(10):1261. doi: 10.1136/heart.89.10.1261.
2
Neonatal flecainide toxicity following supraventricular tachycardia treatment.室上性心动过速治疗后新生儿氟卡尼毒性反应
Ann Pharmacother. 2003 Sep;37(9):1343-4. doi: 10.1345/aph.1C487.
3
Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia.胎儿室上性心动过速治疗后因氟卡尼剂量超治疗量导致的新生儿心电图改变。
Heart. 2003 Apr;89(4):470. doi: 10.1136/heart.89.4.470-a.
4
Ventricular fibrillation following adenosine therapy for supraventricular tachycardia in a neonate with concealed Wolff-Parkinson-White syndrome treated with digoxin.一名患有隐匿性预激综合征的新生儿，在用洋地黄治疗室上性心动过速时接受腺苷治疗后发生心室颤动。
Pediatr Emerg Care. 1995 Aug;11(4):238-9. doi: 10.1097/00006565-199508000-00013.
5
[Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].[一名患有结构性心脏病的患者在接受氟卡尼治疗症状性心房颤动期间出现危及生命的室性心动过速]
Ned Tijdschr Geneeskd. 2006 May 6;150(18):1027-31.
6
Flecainide toxicity in a neonate with supraventricular tachycardia.一名患有室上性心动过速的新生儿出现氟卡尼中毒。
Heart Lung. 1991 Nov;20(6):689-91.
7
[Arrhythmogenic effect of flecainide--treatment with i.v. magnesium].[氟卡尼的致心律失常作用——静脉注射镁治疗]
Z Kardiol. 1989 Sep;78(9):602-6.
8
Sudden death of a horse with supraventricular tachycardia following oral administration of flecainide acetate.一匹马口服醋酸氟卡尼后因室上性心动过速猝死。
J Vet Emerg Crit Care (San Antonio). 2014 Nov-Dec;24(6):759-63. doi: 10.1111/vec.12251. Epub 2014 Nov 11.
9
Antiarrhythmic Agent Induced Ventricular Tachycardia.抗心律失常药物所致室性心动过速
Am J Ther. 2017 Jul/Aug;24(4):e487. doi: 10.1097/MJT.0000000000000483.
10
Unusual Wide Complex Tachycardia During Rhythm Control for Atrial Fibrillation.心房颤动节律控制期间出现的异常宽QRS波心动过速。
Circulation. 2018 Jul 31;138(5):537-539. doi: 10.1161/CIRCULATIONAHA.118.036071.
引用本文的文献
1
Pediatric flecainide pharmacogenomics: a roadmap to delivering precision-based care to pediatrics arrhythmias.小儿氟卡尼药物基因组学：为小儿心律失常提供精准医疗的路线图。
Front Pharmacol. 2024 Dec 16;15:1477485. doi: 10.3389/fphar.2024.1477485. eCollection 2024.
2
Case report: Use of therapeutic drug monitoring and pharmacogenetic testing as opportunities to individualize care in a case of flecainide toxicity after fetal supraventricular tachycardia.病例报告：胎儿室上性心动过速后氟卡尼中毒病例中，利用治疗药物监测和药物遗传学检测实现个体化治疗
Front Pediatr. 2023 Jun 28;11:1168619. doi: 10.3389/fped.2023.1168619. eCollection 2023.
本文引用的文献
1
Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia.胎儿室上性心动过速治疗后因氟卡尼剂量超治疗量导致的新生儿心电图改变。
Heart. 2003 Apr;89(4):470. doi: 10.1136/heart.89.4.470-a.
2
Exercise induced widening of the QRS complex in a patient on flecainide.氟卡尼治疗患者运动诱发的QRS波群增宽
Heart. 2001 Apr;85(4):423. doi: 10.1136/heart.85.4.423.
3
Flecainide induced atrial tachycardia with 1:1 ventricular conduction during exercise testing.在运动试验期间，氟卡尼诱发了伴有1:1心室传导的房性心动过速。
Pacing Clin Electrophysiol. 1994 Sep;17(9):1509-14. doi: 10.1111/j.1540-8159.1994.tb01516.x.
4
Flecainide toxicity in a neonate with supraventricular tachycardia.一名患有室上性心动过速的新生儿出现氟卡尼中毒。
Heart Lung. 1991 Nov;20(6):689-91.
Zotero 插件